DE60330949D1 - Therapeutisches system für die kontrollierte freisetzung von wirkstoffen - Google Patents

Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Info

Publication number
DE60330949D1
DE60330949D1 DE60330949T DE60330949T DE60330949D1 DE 60330949 D1 DE60330949 D1 DE 60330949D1 DE 60330949 T DE60330949 T DE 60330949T DE 60330949 T DE60330949 T DE 60330949T DE 60330949 D1 DE60330949 D1 DE 60330949D1
Authority
DE
Germany
Prior art keywords
active substances
release
tablet
constituted
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60330949T
Other languages
German (de)
English (en)
Inventor
Lauretta Maggi
Ubaldo Conte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Application granted granted Critical
Publication of DE60330949D1 publication Critical patent/DE60330949D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60330949T 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen Expired - Lifetime DE60330949D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI000514A ITMI20020514A1 (it) 2002-03-12 2002-03-12 Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
PCT/EP2003/002536 WO2003075897A1 (en) 2002-03-12 2003-03-12 Therapeutic system for the controlled release of active ingredients

Publications (1)

Publication Number Publication Date
DE60330949D1 true DE60330949D1 (de) 2010-03-04

Family

ID=11449490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60330949T Expired - Lifetime DE60330949D1 (de) 2002-03-12 2003-03-12 Therapeutisches system für die kontrollierte freisetzung von wirkstoffen

Country Status (12)

Country Link
US (1) US20050095295A1 (https=)
EP (1) EP1482915B1 (https=)
JP (1) JP4664595B2 (https=)
CN (1) CN100528146C (https=)
AT (1) ATE454887T1 (https=)
AU (1) AU2003239789A1 (https=)
CA (1) CA2478406C (https=)
DE (1) DE60330949D1 (https=)
DK (1) DK1482915T3 (https=)
ES (1) ES2339438T3 (https=)
IT (1) ITMI20020514A1 (https=)
WO (1) WO2003075897A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
WO2004084868A1 (en) 2003-03-26 2004-10-07 Egalet A/S Morphine controlled release system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US8163306B2 (en) * 2003-09-19 2012-04-24 Sun Pharma Advanced Research Company Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US20060280788A1 (en) * 2005-05-09 2006-12-14 Casey Stephen M Delivery and formulations of mast cell stabilizers
CA2611081C (en) * 2005-06-03 2016-05-31 Egalet A/S A drug delivery system for delivering active substances dispersed in a dispersion medium
EP1948138A4 (en) * 2005-11-18 2012-07-11 Accu Break Technologies Inc SEGMENTED PHARMACEUTICAL DOSAGE FORMS
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
AU2009308885A1 (en) * 2008-10-31 2010-05-06 Mcneil-Ppc, Inc. Osmotic tablet with a compressed outer coating
NZ594207A (en) 2009-02-06 2013-03-28 Egalet Ltd Immediate release composition resistant to abuse by intake of alcohol
WO2010088911A1 (en) 2009-02-06 2010-08-12 Egalet A/S Pharmaceutical compositions resistant to abuse
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
AU2012277375A1 (en) * 2011-06-29 2014-01-30 Sun Pharmaceutical Industries Limited Multilayered dosage form
BR112015000150A2 (pt) 2012-07-06 2017-06-27 Egalet Ltd composições farmacêuticas dissuasoras de abuso de liberação controlada
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
WO2017136617A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
AU2017261372B2 (en) * 2016-05-05 2019-02-14 Triastek, Inc. Controlled release dosage form
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
EP3970701B1 (en) * 2018-06-27 2025-05-07 Amneal Complex Products Research LLC Self-regulating osmotic gastroretentive drug delivery systems
WO2020027927A1 (en) * 2018-07-30 2020-02-06 Insta Therapeutics, Inc. Sublingual diltiazem and methods of use
CN113274363B (zh) * 2021-04-29 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
IT1201136B (it) * 1987-01-13 1989-01-27 Resa Farma Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5376771A (en) * 1992-07-07 1994-12-27 Merck & Co., Inc. High speed process for preparing orifices in pharmaceutical dosage forms
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
CN2213539Y (zh) * 1994-04-29 1995-11-29 天津市激光技术研究所 包衣上带有小孔的缓释药片
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US5783793A (en) * 1996-02-29 1998-07-21 Merck & Co., Inc. Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
CA2261787C (en) * 1997-05-30 2006-11-14 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
US6004584A (en) * 1998-03-02 1999-12-21 The Procter & Gamble Company Highly absorbent body powders
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento

Also Published As

Publication number Publication date
US20050095295A1 (en) 2005-05-05
ES2339438T3 (es) 2010-05-20
CA2478406C (en) 2011-02-08
ITMI20020514A0 (it) 2002-03-12
EP1482915B1 (en) 2010-01-13
WO2003075897A1 (en) 2003-09-18
JP4664595B2 (ja) 2011-04-06
CN100528146C (zh) 2009-08-19
EP1482915A1 (en) 2004-12-08
ITMI20020514A1 (it) 2003-09-12
JP2005526757A (ja) 2005-09-08
CN1649571A (zh) 2005-08-03
ATE454887T1 (de) 2010-01-15
DK1482915T3 (da) 2010-04-19
CA2478406A1 (en) 2003-09-18
AU2003239789A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
DE60330949D1 (de) Therapeutisches system für die kontrollierte freisetzung von wirkstoffen
Janczura et al. The development of innovative dosage forms of the fixed-dose combination of active pharmaceutical ingredients
JP2005526757A5 (https=)
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
DE602004006497D1 (de) Wasserlösliches abgabeprodukt
AR028849A1 (es) Articulo absorbente
BR0315023A (pt) Distribuidor de composição anti-séptica de pele e método de preparar um distribuidor de composição anti-séptica de pele para uso
ES2033572A1 (es) Saquitos solubles.
ATE446087T1 (de) Mikrokügelchen mit nanokapseln, die ein lipophiles arzneimittel enthalten
CO6290635A2 (es) Composición farmaceútica que comprende una forma de dosis unitaria sólida de uno o más ingredientes activos y un polímero insoluble en agua y/o un polímero soluble en agua
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
AR033418A1 (es) Preparado farmaceutico mucoadhesivo desintegrable para la administracion de sustancia activa en medicina veterinaria y humana
AR034517A1 (es) Formulacion farmaceutica
AR036838A1 (es) Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende.
DK0406779T3 (da) Indretning til afgivelse af systemiske virksomme stoffer til planter og anvendelse heraf
ATE534345T1 (de) Endovaskuläre vorrichtung mit membran
WO2013019930A2 (en) Decomposable apparatus and methods for fabricating same
BRPI0315461B8 (pt) sistema terapêutico em forma de película
DE60128263D1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
AR111216A1 (es) Dispositivo de integración celular o tisular
BRPI0812332A2 (pt) Embalagem para produtos de tabaco, e, método para fabricar a mesma
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
PA8548301A1 (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
WO2003075894A8 (en) A system for the controlled release of active ingredients

Legal Events

Date Code Title Description
8364 No opposition during term of opposition